MARKET

ASRT

ASRT

Assertio Holdings Inc
NASDAQ
1.040
-0.030
-2.80%
Pre Market: 1.070 +0.03 +2.88% 09:25 05/21 EDT
OPEN
1.030
PREV CLOSE
1.070
HIGH
1.060
LOW
1.010
VOLUME
2.17K
TURNOVER
0
52 WEEK HIGH
7.40
52 WEEK LOW
0.7324
MARKET CAP
98.93M
P/E (TTM)
-0.2631
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ASRT last week (0513-0517)?
Weekly Report · 1d ago
BUXTON HELMSLEY GROUP: URGES ASSERTIO STOCKHOLDERS TO VOTE AGAINST ALL DIRECTORS AT UPCOMING ANNUAL MEETING
Reuters · 4d ago
Assertio to Participate in Benchmark Healthcare Conference on May 21-22
Assertio Holdings, Inc. Will host investor meetings as part of the Benchmark & Company Healthcare House Call Virtual Conference in May 21-22, 2024. Ajay Patel, Chief Financial Officer of Assertio, will host the investor meetings. The company is a pharmaceutical company.
Barchart · 4d ago
Assertio to Participate in AGP Healthcare Conference on May 21
Assertio Holdings, Inc. Will present at the Alliance Global Partners Virtual Healthcare Company Showcase to be held virtually on May 21, 2024. Ajay Patel, Chief Financial Officer, will present an overview of Assertio’s business at 3:40 p.m. Eastern Time.
Barchart · 5d ago
BUXTON HELMSLEY SAYS IT URGES ASSERTIO STOCKHOLDERS TO IMMEDIATELY CAST VOTES "AGAINST" ALL OF ASSERTIO DIRECTOR NOMINEES - SEC FILING
Reuters · 6d ago
BUXTON HELMSLEY GROUP SAYS HAS DEMANDED TWO SEATS ON ASSERTIO BOARD
Reuters · 05/13 21:53
BUXTON HELMSLEY URGES ASSERTIO STOCKHOLDERS TO VOTE "AGAINST" DIRECTORS AFTER DISCLOSURE FAILURES, INAPPROPRIATE BOARDROOM ACTIVITY, STRATEGIC BLUNDERS
Barchart · 05/13 16:52
Weekly Report: what happened at ASRT last week (0506-0510)?
Weekly Report · 05/13 11:17
More
About ASRT
Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).

Webull offers Assertio Holdings Inc stock information, including NASDAQ: ASRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASRT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASRT stock methods without spending real money on the virtual paper trading platform.